|
Volumn 61, Issue 4, 2001, Pages 1272-1275
|
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BATIMASTAT;
COMPLEMENTARY DNA;
HYDROXAMIC ACID DERIVATIVE;
MATRIX METALLOPROTEINASE INHIBITOR;
MESSENGER RNA;
ANGIOGENESIS;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
ENZYME INHIBITION;
EXPERIMENTAL MODEL;
FEMALE;
GENE OVEREXPRESSION;
LIVER CANCER;
LIVER METASTASIS;
LYMPHOMA CELL;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
TISSUE SPECIFICITY;
ANGIOGENESIS INDUCING AGENTS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CASPASE 1;
FEMALE;
HUMANS;
LIVER;
LIVER NEOPLASMS, EXPERIMENTAL;
LUNG NEOPLASMS;
LYMPHOMA, T-CELL;
MAMMARY NEOPLASMS, EXPERIMENTAL;
MATRIX METALLOPROTEINASE 2;
MATRIX METALLOPROTEINASE 9;
MICE;
MICE, INBRED DBA;
MICE, NUDE;
NEOPLASM TRANSPLANTATION;
OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;
PHENYLALANINE;
PROTEASE INHIBITORS;
RNA, MESSENGER;
THIOPHENES;
UP-REGULATION;
|
EID: 0035866362
PISSN: 00085472
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (123)
|
References (24)
|